Tags : VO659

Regulatory

Vico’s VO659 Receives EC’s Orphan Drug Designation for Spinocerebellar Ataxia

Shots: The EC granted ODD for VO659 for the treatment of spinocerebellar ataxia (SCA). The ODD was based on a EMA’s COMP positive opinion The company previously received ODD in Huntington Disease The company focused on the development of RNA modulating therapies for rare neurological disorders VO659 is an antisense oligonucleotide product, designed to suppress […]Read More